Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report)’s share price dropped 47.9% on Tuesday . The company traded as low as $1.30 and last traded at $1.35. Approximately 1,200 shares changed hands during trading, a decline of 58% from the average daily volume of 2,886 shares. The stock had previously closed at $2.59.
Idorsia Trading Down 4.4 %
The company’s 50-day moving average is $2.53 and its 200-day moving average is $2.41.
Idorsia Company Profile
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
Recommended Stories
- Five stocks we like better than Idorsia
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What is a buyback in stocks? A comprehensive guide for investors
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Why Are These Companies Considered Blue Chips?
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.
-POPCAT.png?v=2024-04-21&h=45&w=95&zc=2){kind=small}
